“At SCHWIND, innovation is not just a goal — it is the foundation of who we are,” says Dr. Martin Leitner, CTO of SCHWIND eye-tech-solutions.
SCHWIND systems are CE marked under EU-MDR standards and are trusted in over 100 countries by clinics, laser centers, and university hospitals. This certification reflects SCHWIND’s commitment to safety, performance, and quality while allowing to remain agile and focus on strategically important markets. The believe in innovation requires freedom—the freedom to continuously evolve and respond to clinical needs. Therefore, SCHWIND has chosen not to pursue U.S. FDA approval for the laser systems for now, instead investing in technological advancement. This strategy has established SCHWIND AMARIS as a leader in excimer lasers and supports the ongoing evolution of our SCHWIND ATOS system.
Close collaboration with leading surgeons and academic institutions worldwide ensures that developments are guided by real clinical experience. High user satisfaction and excellent patient outcomes confirm the strength of this approach. At SCHWIND, innovation never stands still.
